moderna shares are trading at a more reasonable valuation for the first time since analysts at redburn launched coverage of the stock in november 2020 and because of that redburn boosted its rating on shares of the vaccine maker to neutral from sell shares of moderna ticker mrna were up 26 on tuesday to 17371 the stock has fallen nearly 32 year to date after rising 143 last year